共 21 条
- [10] Berlin, 22.10.2018. 270th Statement of the Working Group of Gynecological Oncology (AGO) e. V. in the German Society for Gynecology and Obstetrics (DGGG) e. V. on the Subject of Pertuzumab (Breast Cancer) - Benefit Assessment according to 35a SGB V GEBURTSHILFE UND FRAUENHEILKUNDE, 2019, 79 (04) : 344 - 350